Control de Calidad de Peptidos Farmaceuticos
Categorías: Metodología de Investigación, Control de Calidad, Información General
El control de calidad farmaceutico asegura que cada batch de peptido cumple especificaciones. Sistema integrado de pruebas y documentacion es obligatorio.
Resumen Simplificado
QC de peptidos incluye identity, purity, potency, impurities, sterility y stability; sistema GMP con specifications y release criteria.
Sistema de control de calidad
QC es sistema integrado. GMP framework. Good Manufacturing Practice. Regulations. FDA 21 CFR. EMA GMP. ICH guidelines. Local requirements. Chile ISP. Components. Quality control laboratory. Testing capabilities. Personnel. Qualified analysts. Training documented. Equipment. Qualified. Calibrated. Maintained. Methods. Validated. Current. Documentation. SOPs. Protocols. Reports. Batch records. Data integrity. ALCOA. Attributable. Legible. Contemporaneous. Original. Accurate. Release process. Testing complete. Specifications met. Data reviewed. Quality unit approval. Certificate of analysis. Batch release. QC ensures quality. Not tests quality in. Product must be built right. QC verifies.
Especificaciones de release
Specifications define quality. Development. Based on process capability. Stability data. Clinical experience. Regulatory requirements. Typical specifications. Identity. MS match. Correct mass. Sequence confirmation. MS/MS. Assay. 95-105% of label. Potency. Biological activity. If applicable. Related substances. Individual impurities. Each specified. Typically 1-2% max. Total impurities. Sum of all. Typically 3-5% max. Water content. Karl Fischer. Typically less than 5-10%. Residual solvents. ICH Q3C limits. Heavy metals. If applicable. pH. For solutions. Appearance. Color. Clarity. Particulates. For parenterals. Sterility. If sterile product. Endotoxin. LAL test. For injectable. Setting specifications. Must be achievable. Must be meaningful. Must ensure safety. Specifications are contract. Between manufacturer. And user. And regulator.
Pruebas de identidad y pureza
Identity is primary. Confirm correct peptide. Methods. Mass spectrometry. ESI-MS. MALDI-TOF. Exact mass. Delta less than 5 ppm. MS/MS sequencing. Peptide mapping. Enzymatic digest. LC-MS analysis. Amino acid analysis. Composition. Peptide content. Nitrogen determination. Purity assessment. HPLC. Primary method. Area percent. Main peak area. Related substances. Impurity profile. Specific impurities. Known degradants. Process impurities. Unknown peaks. Reporting. Identification above threshold. Quantification all peaks. Capillary electrophoresis. Complementary. For charge variants. SDS-PAGE. For larger peptides. Visual assessment. Purity and identity together. Confirm product is correct. And meets quality. Both required for release.
Ensayos de potencia y actividad
Potency for bioactive peptides. Biological activity. Functional assay. Receptor binding. IC50, EC50. Compare to reference. Cell-based assays. Functional response. Reporter gene. Second messenger. Signaling. Enzyme inhibition. Ki determination. Substrate turnover. In vivo assays. If no surrogate. Animal models. Pharmacological response. Potency units. International units. If standard exists. Relative potency. Vs internal reference. Method validation. Specificity. Accuracy. Precision. Linearity. Range. Parallelism. For relative potency. Reference standard. Primary. Characterized extensively. Secondary. Calibrated vs primary. Working. For routine use. Stability monitored. Potency testing confirms. Activity is present. Consistent with specification. Critical for therapeutic peptides.
Pruebas de impurezas y contaminantes
Impurities must be controlled. Types. Process-related. From synthesis. Reagents. Byproducts. Product-related. Variants of target. Degradants. Modifications. Process impurities. Residual solvents. GC analysis. ICH limits. Reagents. Free amino acids. Activators. Protecting groups. Method-specific. Heavy metals. ICP-MS. AAS. ICH Q3D. Elemental limits. Product-related impurities. Related substances. HPLC profile. Identified peaks. Unknown peaks. Aggregates. SEC analysis. Charge variants. IEX or CE. Disulfide isomers. RP-HPLC. Peptide mapping. Contaminants. Bioburden. Microbial limits. Sterility. If sterile product. Endotoxins. LAL test. Bacterial DNA. qPCR. Host cell proteins. ELISA. For recombinant peptides. Impurity control is safety. Each type addressed. Methods validated. Specifications set. Monitored trend.
Documentacion y liberacion de lotes
Documentation is essential. Batch record. Manufacturing record. All steps. Materials used. Conditions. Yields. Deviations. In-process tests. Analytical record. Sample log. Chain of custody. Testing protocols. Raw data. Calculations. Results. Review and approval. Analyst check. Supervisor review. Quality approval. Data integrity. Audit trail. Electronic records. 21 CFR Part 11. Certificate of analysis. Product identification. Batch number. Manufacture date. Expiry date. Specifications. Test methods. Results. Pass/fail. Release statement. Authorized signature. Date. Retention samples. Sufficient quantity. For retest. Full shelf life plus one year. Stability samples. For ongoing monitoring. Regulatory submissions. Batch analysis. CMC section. Documentation proves quality. Enables traceability. Supports regulatory compliance. Protects patients.
Hallazgos Clave
- QC farmaceutico opera bajo GMP con laboratorio calificado, metodos validados y data integrity
- Specifications incluyen identity, assay 95-105%, impurities <1-2% individual, <3-5% total
- Identity por MS (exact mass, MS/MS), peptide mapping y amino acid analysis
- Potency se mide por binding assays, cell-based assays o in vivo; relative potency vs reference
- Impurities incluyen process-related (solvents, reagents) y product-related (degradants, aggregates)
- Documentation incluye batch record, analytical record, CoA, retention samples y audit trail
Más artículos en Metodología de Investigación
Más artículos en Control de Calidad
Artículos relacionados
Términos del glosario
Preguntas frecuentes
- Que pruebas tipicas incluye el release de un peptido?
- Identity (MS, peptide mapping), assay/potency (95-105%), related substances (individual <1-2%, total <3-5%), water content, residual solvents, heavy metals, appearance, pH si es solucion, sterility y endotoxins si es parenteral. CoA documenta todos los resultados.
- Como se determina la potencia de un peptido?
- Metodo biologico relevante: receptor binding assay (IC50), cell-based assay (functional response), enzyme inhibition (Ki). Se compara con reference standard. Relative potency = 100% si es equivalente al reference. Metodo debe estar validado.
- Que es ALCOA en data integrity?
- Attributable (quien hizo, cuando), Legible (clara, permanente), Contemporaneous (registrada al momento), Original (primera captura, no copia), Accurate (correcta, sin errores). Son principios fundamentales para data integrity en GMP.
- Que muestras deben retenerse?
- Retention samples: cantidad suficiente para retest completo, almacenadas bajo condiciones apropiadas, por shelf-life mas un ano. Stability samples: para monitoreo continuo. Reference standards: para calibration. Todas trazables al batch.